Bibliographic information
GuidelineMedical eligibility criteria for contraceptive use, 6th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization
Recommendation
Maintained
Women living with asymptomatic or mild HIV clinical disease (WHO stage 1 or 2) can use the following hormonal contraceptive methods without restriction: combined oral contraceptive (pill) (COCs), combined injectable contraceptives (CICs), combined contraceptive patches and rings, progestogen-only pill(POPs), progestogen-only injectable(POIs) (DMPA and NET-EN), and levonorgestrel (LNG) and etonogestrel(ETG) implants
Certainty of evidence
Moderate
Notes and Remarks
Because there may be drug interactions between hormonal contraceptives and antiretroviral therapy (ART), refer to the last section of this (the guideline) table, on drug interactions
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Medical eligibility criteria for contraceptive use
Year2015
InstitutionWorld Health Organization